title: Harvoni (Ledipasvir With Sofosbuvir)-Induced Renal Injury.
authors.affiliation: Medicine, Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra North Shore LIJ School of Medicine, Great Neck, New York, USA.
authors.forename: Rimda
authors.initials: R
authors.lastname: Wanchoo
authors.affiliation: Medicine, Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra North Shore LIJ School of Medicine, Great Neck, New York, USA.
authors.forename: Jyotsana
authors.initials: J
authors.lastname: Thakkar
authors.affiliation: Department of Pathology, Montefiore Medical Center, Albert Einstein School of Medicine, New York, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Schwartz
authors.affiliation: Medicine, Division of Kidney Diseases and Hypertension, North Shore University Hospital and Long Island Jewish Medical Center, Hofstra North Shore LIJ School of Medicine, Great Neck, New York, USA.
authors.forename: Kenar D
authors.initials: KD
authors.lastname: Jhaveri
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000998:Antiviral Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects*; D005260:Female; D005449:Fluorenes / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; C000595958:ledipasvir, sofosbuvir drug combination; D014542:Uridine Monophosphate; D000069474:Sofosbuvir